MHLW

AcronymDefinition
MHLWMinistry of Health, Labor and Welfare (Japan; formerly Ministry of Health and Welfare, MHW)
MHLWMean High Low Water (tide level)
References in periodicals archive ?
2 , 3 BAVENCIO previously received Orphan Drug Designation from the MHLW in December 2016.
Officials from prefectures in which cases were confirmed made public announcements for most of these cases, and the MHLW issued a press release to convey the information nationwide.
Japan has about 310 officers, including MHLW and PMDA, and its safety division has only 66 officers in charge.
The strong MHLW support for products addressing Metabolic Syndrome is an important new development, however.
The MHLW has added methylisothiazolinone to the positive list of preservatives approved for use in leave-on and rinse-off cosmetic products at a maximum dosage of 100ppm.
2, 2001 -- The MHLW bans the use of domestically raised ruminants such as cow and sheep as raw material for medicines and cosmetics.
Before Medtronic can begin commercialization, it must partner with Japanese MHLW to gain reimbursement to ensure broader access to this innovative and clinically-proven therapy.
The company established commercial operations in Japan in March 2015 after the MHLW approved Optune for the treatment of recurrent GBM.
M2 EQUITYBITES-December 5, 2016-GlaxoSmithKline and Innoviva win MHLW approval in Japan for Relvar Ellipta 100/25 mcg for the treatment of COPD
In October 2010, the MHLW approved the indication of ankylosing spondylitis for HUMIRA with the following condition for approval: "Because of the very limited number of subjects treated in the Japanese clinical trials, the applicant is required to conduct all-case drug use-results survey until data from a certain number of patients are accumulated after market launch, in order to identify the background information of patients treated with the product and collect safety and efficacy data on the product in the early post-marketing period, and thereby take necessary measures to ensure proper use of the product.
The pharmaceutical companies felt that labeled health claims for foods, specifically approved by the MHLW, would negatively impact their prescription drug businesses (they were probably correct).